Cargando…

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance

Detalles Bibliográficos
Autores principales:	Chauhan, Shailender S., Warfel, Noel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231444/ https://www.ncbi.nlm.nih.gov/pubmed/30460324 http://dx.doi.org/10.18632/oncoscience.458

Ejemplares similares

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
por: Toth, Rachel K., et al.
Publicado: (2022)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
por: Clements, Amber N., et al.
Publicado: (2022)

Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors
por: Casillas, Andrea L., et al.
Publicado: (2021)

Insulin receptor substrate 1 is a substrate of the Pim protein kinases
por: Song, Jin H., et al.
Publicado: (2016)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
por: Stafman, Laura L., et al.
Publicado: (2018)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
por: Lang, Frederick M., et al.
Publicado: (2020)

PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion
por: Jensen, Corbin C., et al.
Publicado: (2023)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics
por: Wang, Yixin, et al.
Publicado: (2021)

PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2014)

The PIM family of oncoproteins: Small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets
por: Saurabh, Kumar, et al.
Publicado: (2014)

LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)

microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase
por: Zhang, You, et al.
Publicado: (2016)

Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
por: Toth, Rachel K., et al.
Publicado: (2017)

Opposing function of mitochondrial prohibitin in aging
por: Artal-Sanz, Marta, et al.
Publicado: (2010)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
por: Brault, L, et al.
Publicado: (2012)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
por: Warfel, Noel A.
Publicado: (2022)

A review on PIM kinases in tumors
por: Arrouchi, Housna, et al.
Publicado: (2019)

The Pim kinases control rapamycin-resistant T cell survival and activation
por: Fox, Casey J., et al.
Publicado: (2005)

Targeting Pim kinases in hematological cancers: molecular and clinical review
por: Bellon, Marcia, et al.
Publicado: (2023)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy
por: Koike, Akito, et al.
Publicado: (2022)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

NDRG3-mediated lactate signaling in hypoxia
por: Park, Kyung Chan, et al.
Publicado: (2015)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
por: Mahalingam, D, et al.
Publicado: (2011)

Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication
por: Sugasti-Salazar, Madelaine, et al.
Publicado: (2022)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2021)

An opposing view on including high school students in a latent tuberculosis infection control program in Korea
por: Bae, Jong-Myon
Publicado: (2017)

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset
por: Padi, Sathish K.R., et al.
Publicado: (2017)

PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism
por: Serrano-Saenz, Santiago, et al.
Publicado: (2019)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fo73m5u9u53j1lgj9vavub9gve